China Health Group Inc.
Hong Kong Stock ExchangeTotal Valuation
China Health Group Inc. carries a market capitalization of 94.56M, placing it among publicly traded companies globally. Its enterprise value stands at 116.92M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 94.56M |
| Enterprise Value | 116.92M |
Share Statistics
China Health Group Inc. currently has 995.35M shares outstanding.
| Shares Outstanding | 995.35M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 5.83, and the price-to-book ratio stands at 3.51.
| PE Ratio | N/A |
| PS Ratio | 5.83 |
| PB Ratio | 3.51 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 5.46 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 14,614.66 |
Financial Position
China Health Group Inc. maintains a current ratio of 3.19, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.19 |
| Quick Ratio | 0.21 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -7,291.37 |
Financial Efficiency
| Return on Equity (ROE) | -90.22 |
| Return on Assets (ROA) | -38.94 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -23.48 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | N/A |
| Effective Tax Rate | 44.94 |
Stock Price Statistics
China Health Group Inc.'s stock has declined approximately -41.35802% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.14.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.35802% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.14 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, China Health Group Inc. generated 21.43M in revenue and converted that into -58.01M in net income, yielding earnings per share of -0.06. EBITDA reached -58.33M, while operating income came in at -58.33M.
| Revenue | 21.43M |
| Gross Profit | 8.21M |
| Operating Income | -58.33M |
| Pretax Income | -58.21M |
| Net Income | -58.01M |
| EBITDA | -58.33M |
| EBIT | -58.33M |
| Earnings Per Share (EPS) | -0.06 |
Balance Sheet
Total book value stands at 35.58M, with working capital of 77.01M providing operational flexibility.
| Cash & Cash Equivalents | 7.30M |
| Total Debt | N/A |
| Net Debt | -4.14M |
| Equity (Book Value) | 35.58M |
| Book Value Per Share | 0.04 |
| Working Capital | 77.01M |
Margins
China Health Group Inc. operates with a gross margin of 38.33, reflecting its pricing power and cost economics. The operating margin of -272.26 and net profit margin of -270.78 provide insight into operational efficiency.
| Gross Margin | 38.33 |
| Operating Margin | -272.26 |
| Pretax Margin | -271.70 |
| Profit Margin | -270.78 |
| EBITDA Margin | -272.26 |
Stock Splits
China Health Group Inc.'s most recent stock split took place on October 13, 2014 with a 500:747 split ratio.
| Last Split Date | 10/13/2014 |
| Split Ratio | 500:747 |
Scores
China Health Group Inc. posts an Altman Z-Score of 0.85, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.85 |